Roche (4 pharmaceutical products) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Roche (4 pharmaceutical products) General Information
Description
A portfolio of pharmaceutical products. The portfolio comprises of four products namely Marcoumar, an anticoagulant, Torem , a loop diuretic, Tilcotil , a drug for the treatment of painful inflammatory and degenerative disorders of the musculoskeletal system and Aurorix , a well-known antidepressant.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Grenzacherstrasse 124
- 4070 Basel
- Switzerland
Roche (4 pharmaceutical products) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Roche (4 pharmaceutical products) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|